The potential risks posed by inter- and intraspecies transmissions of monkeypox virus

Hannah Murphy,Hinh Ly
DOI: https://doi.org/10.1080/21505594.2022.2127199
IF: 5.428
2022-09-26
Virulence
Abstract:Since the 1970s, human cases of monkeypox (MPX) have been reported in 11 African countries (Benin, Cameroon, Central African Republic, the Democratic Republic of the Congo, Gabon, Cote d'Ivoire, Liberia, Nigeria, Republic of the Congo, Sierra Leone, and South Sudan), where the monkeypox virus (MPXV) is endemic [ 1 , 2 ]. However, in 2022, human cases of MPX have been reported in Europe (11,212 confirmed cases as of late August 2022), Canada (1,206), and the United States (16,925) from travelers, who have not traveled to any of the regions, where MPXV is endemic [ 1 , 3 , 4 ]. As the number of human cases of MPX steadily increased outside of these endemic countries, the World Health Organization (WHO) declared it as a Public Health Emergency of International Concern (PHEIC) on 23 July 2022 [ 5 ].
microbiology,immunology,infectious diseases
What problem does this paper attempt to address?